key: cord-0988750-uujocxsb
authors: Magliah, Sultan F.; Zarif, Hawazen A.; Althubaiti, Alaa; Sabban, Mahmoud F.
title: Managing Type 1 Diabetes among Saudi adults on insulin pump therapy during the COVID-19 lockdown
date: 2020-12-06
journal: Diabetes Metab Syndr
DOI: 10.1016/j.dsx.2020.12.013
sha: 71377f2ae73c63200725f29776b3b959c91fdebb
doc_id: 988750
cord_uid: uujocxsb

BACKGROUND AND AIMS: The coronavirus disease 2019 (COVID-19) pandemic has affected people's lives including patients with Type 1 diabetes mellitus (T1DM). We aimed to investigate the impact of the COVID-19 lockdown on psychological status, self-management behaviors, and diabetes care maintenance among Saudi adults with T1DM using insulin pump therapy. METHODS: This cross-sectional study used a web survey to collect data on Saudi adults with T1DM who were treated in the specialized insulin pump clinic at King Abdulaziz Medical City-Jeddah, Saudi Arabia. We used the Patient Health Questionnaire-9 and General Anxiety Disorder-7 scales to measure depression and anxiety. RESULTS: Of the 70 patients who received the survey, 65 completed it. Overall, 23.1% and 29.2% of the patients reported moderate to severe and mild depression, respectively; 18.5% and 24.6% reported moderate to severe and mild anxiety, respectively. Compared with pre-lockdown, adherence to a healthy diet and regular physical activity decreased in 67.7% and 41.5% of the patients, respectively. Most patients maintained their adherence to insulin pump behaviors; frequent self-monitoring of blood glucose increased in 47% of glucometer users. Most patients benefited from phone visits or virtual education sessions, but 66.2% of the patients reported difficulty obtaining at least one type of insulin pump supply. CONCLUSIONS: Promoting self-management behaviors and psychological wellbeing of patients with T1DM using insulin pump therapy is crucial during a lockdown. Telemedicine is a useful alternative to in-person appointments, but strategies to ensure that patients have access to adequate resources during lockdown must be developed.

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) belongs to coronaviruses, 26 which are classified as positive-sense single-stranded RNA viruses. 1 This virus was first 27 identified in Wuhan City, China, in late 2019, and it has been spreading around the world since 28 then. On March 11, 2020 , the World Health Organization declared the outbreak of SARS-CoV-2 29 and its associated disease, coronavirus disease 2019 (COVID-19), a pandemic. 2 In response to 30 the pandemic, many countries instituted lockdowns and social distancing measures to combat the 31 spread of the virus. Specifically, Saudi Arabia imposed a curfew in late March, 3, 4 including 32 transportation restrictions, workplace attendance suspension, closure of malls and markets, and 33 constraints on dining in restaurants. 5 Consequently, customers were heavily dependent on 34 delivery services for their habitual needs. On June 21, 2020, the lockdown was completely lifted 35 off the country. 6 36 Type 1 diabetes mellitus (T1DM) is a chronic disease characterized by the autoimmune 37 destruction of pancreatic beta cells leading to a lack of insulin production. Saudi Arabia has one 38 of the highest incidence rates of T1DM worldwide, with an annual rate of 31.4 cases/100,000 39 individuals in young children (< 15 years old). 7 Insulin pump therapy and multiple daily 40 injections are the two most common treatments to provide intensive insulin therapy. This therapy 41 is associated with a decrease in HbA1c levels and in micro-and macrovascular complications in 42 patients with T1DM. 8 

The COVID-19 pandemic has negatively affected people's lives due to constant stress 44 and fear of contracting the virus. Patients with diabetes habitually experience an increased level 45 of negative emotions, which may lead to poor glycemic control during the pandemic. 9 Diabetes 46 self-management behaviors-practicing physical exercise, maintaining a healthy diet, monitoring J o u r n a l P r e -p r o o f Data Collection 77 The survey contained five parts. The first part included demographic data such as age, sex, level 78 of education, occupation, marital status, smoking history, mental health history, height, and 79 current weight. The second part contained questions about diabetes and insulin pump history, 80 including the type of insulin pump currently used and blood glucose monitoring method.

The third part referred to difficulties faced in maintaining routine care, including virtual 82 appointments, virtual education, and availability of insulin pump-related supplies. Patients were 83 asked if they had a scheduled phone appointment with a physician during the lockdown period, 84 and whether the encounter was beneficial; whether they received virtual education by a diabetic 85 educator or physician, the method of communication used, and whether the encounter was 86 beneficial; which insulin pump supply they had difficulty obtaining, if any, and whether they had 87 to use multiple daily injections instead of the insulin pump due to lack of supplies.

The fourth part assessed the impact of the lockdown on different self-management 89 behaviors. Patient were asked to report any perceived weight change in kilograms and to rate the 90 following behaviors in comparison with the pre-lockdown period: ability to follow a healthy diet, 91 ability to maintain physical activity, and experience of hyperglycemia or hypoglycemia 92 symptoms. In addition, patients were asked to report any change in the adherence level to different insulin pump behaviors: carbohydrate counting, use of bolus wizard during mealtimes, 94 use of bolus wizard for correction of hyperglycemia, and frequent self-monitoring of blood 95 glucose (≥ 4 times/day) for glucometer users.

The fifth part assessed the psychological status during the lockdown. We used the Arabic 97 versions of the Patient Health Questionnaire-9 (PHQ-9) and General Anxiety Disorder-7 (GAD-98 7) scales to measure depression and anxiety, respectively. Pre-lockdown HbA1c level was 99 obtained from the hospital's electronic medical record system. 

The PHQ-9 and GAD-7 scales are validated tools for the screening of depression and anxiety in 103 clinical practice. 11, 12 The Arabic versions of both questionnaires were previously validated based 104 on a sample of Saudi adults. 13 

The PHQ-9 (11) contains nine questions pertaining depression symptoms included in the 106 Diagnostic and Statistical Manual of Mental Disorders (4th edition) diagnostic criteria for major 107 depressive disorder. Patients were asked how often they experienced any depression symptom in 108 the past 14 days. The responses for each question were "not at all", "several days", "more than 109 half the days", and "nearly every day", with a corresponding score of 0, 1, 2, and 3, respectively.

The total score was the sum of the scores of all the questions. Cut-off points of 5, 10, 15, and 20 111 were used to represent mild, moderate, moderately severe, and severe depression, respectively. A 112 PHQ-9 score ≥ 10 was used to define moderate to severe depression.

The GAD-7 (12) uses seven questions to evaluate the presence and severity of generalized 114 anxiety disorder in clinical practice. Patients were asked how often they experienced any anxiety 115 symptom in the past four weeks. The responses for each question were "not at all", "several days", "more than half the days", and "nearly every day", with a corresponding score of 0, 1, 2, 117 and 3, respectively. The total score was the sum of the scores of all the questions. Cut-off points 118 of 5, 10, and 15 were used to represent mild, moderate, and severe anxiety, respectively. A 119 GAD-7 score ≥ 10 was used to define moderate to severe anxiety. Descriptive data were presented as mean (± standard deviation). Categorical variables were 123 presented as frequencies and percentages. To determine associations between different self-124 management behavioral changes that occurred during the lockdown, we combined "greatly 125 increased" with "somewhat increased", and "greatly decreased" with "somewhat decreased" 126 ratings to facilitate interpretation. Differences between groups were analyzed using the chi-127 squared test or Fisher's exact test for categorical data. A P-value <0.05 was considered 

Of 70 patients attending the specialized insulin pump clinic who received the survey, 65 134 completed the questionnaire. Among those who did not complete it, four did not respond and one 135 refused to participate. Table 1 summarizes the participants' demographic characteristics. The and moderate to severe anxiety (66.7% vs. 13.6%, P = 0.009) than those who did not have a 151 history of mental disorders. Furthermore, 19 patients (29.2%) had mild depression (PHQ-9 score 152 5-9), and 16 patients (24.6%) had mild anxiety (GAD-7 score 5-9). Table 2 shows the 153 distribution of depression and anxiety by severity degree in the participants of our study. lancets, test strips, and/or alcohol swabs, and 5 patients (7.7%) for glucometer device. The 203 frequency of using multiple daily injections (insulin pen/syringe) for blood sugar control during 204 lockdown due to lack of insulin pump resources was "never" for 56 patients (86.2%), "rarely" Health Questionnaire-12. 16 In contrast, a Saudi study including 394 patients with type 2 diabetes 224 reported that the COVID-19 lockdown had minimal impact on psychological health as measured negatively affected by the lockdown because of the lack of baseline psychological assessment. Adherence to insulin pump behaviors is essential for optimal glucose control. Behaviors 251 such as carbohydrate counting, use of bolus wizard, and frequency of blood sugar measurements 252 are associated with better glycemic control. 23, 24 In this study, the level of adherence to insulin 253 pump behaviors was largely not adversely affected compared with pre-lockdown behaviors (Table 4) . Additionally, the majority of glucometer users reported increased adherence to self-255 monitoring of blood glucose 4 or more times daily. In contrast, a cross-sectional telephone-based 256 study in India that interviewed 30 young adults with T1DM using multiple daily injections found 257 that one third of the participants self-monitored blood glucose less frequently during the 258 lockdown because of financial issues or limited accessibility to glucometers. They also reported 259 that most participants had a decrease in physical activity and an increase in glucose level 260 readings during the same period, despite their routine diet remaining unchanged. 25 The positive 261 changes observed in our study may be attributed to increased spare time to manage diabetes and The continuous spread of the virus required the implementation of telemedicine services 267 to replace in-person routine appointments, impacting the maintenance of optimal diabetes care.

Scientific evidence supports the use of telemedicine for patients with diabetes; moreover, 269 patients were able to easily contact their health care providers from their home, decreasing 270 hospital visits and, consequently, the risk of contracting the virus. 27 In the first two weeks of 271 lockdown, the specialized clinic temporarily closed and appointments were rescheduled for the 272 next available slots. In the following weeks, physicians attended routine phone call appointments Access to medical supplies was another challenge during the lockdown. In a cross-292 sectional Indian study including 52 young patients with T1DM using multiple daily injections, 293 lack of insulin and glucostrips was associated with impaired glycemic control during the first 15 294 days of lockdown, which was presumably attributable to inadequate stock of supplies and limited 295 transportation. 29 As expected, almost 67% of participants experienced difficulty obtaining insulin 296 pump resources. Specifically, those using flash or continuous glucose monitoring were more 297 affected than glucometer users because sensor supplies were likely to be depleted sooner.

Participants also frequently reported difficulty obtaining infusion sets, insulin reservoirs, and 299 insulin. Movement restrictions and fear of getting infected when leaving the house contributed to this situation. Despite these difficulties, most patients were adequately stocked on supplies 301 before the lockdown, and very few had to frequently use multiple daily injections for blood sugar 302 control due to lack of supplies. The fact that insulin pump supplies are regularly provided free of 303 charge to patients in our specialized clinic may have contributed to this.

Our findings should be interpreted carefully because of the study limitations, such as the 305 small sample size and susceptibility to recall bias. 30 Nonetheless, our study had an excellent 306 response rate, because many patients were interested in sharing their experience during the 307 lockdown. To the best of our knowledge, our study was the first to explore the impact of the 

Previously diagnosed with mental disorder 6 (9.2) Not known to have any mental disorder 59 (90.8) Abbreviations: T1DM, type 1 diabetes mellitus; SMBG, self-monitoring of blood glucose; FGM, flash glucose monitoring; CGM, continuous glucose monitoring, ASCVD, atherosclerotic Table 2 Severity distribution of depression and anxiety.

Depression severity (PHQ-9 score range) None or minimal (0-4) 31 (47.7) Mild (5) (6) (7) (8) (9) 19 (29.2) Moderate (10) (11) (12) (13) (14) 10 (15.4) Moderately severe (15) (16) (17) (18) (19) (20) 4 (6.2) Severe (20) (21) (22) (23) (24) (25) (26) (27) 1 (1.5) Anxiety severity (GAD-7 score range) None or minimal (0-4) 37 (56.9) Mild (5-9) 16 (24.6) Moderate (10) (11) (12) (13) (14) 7 (10.8) Severe (15) (16) (17) (18) (19) (20) (21) 5 (7.7) Abbreviation: PHQ-9, Patient Health Questionnaire-9; GAD-7, General Anxiety Disorder-7. J o u r n a l P r e -p r o o f Abbreviation: SMBG, self-monitoring of blood glucose. Data are expressed as n (%).

J o u r n a l P r e -p r o o f

Coronavirus genomics and bioinformatics analysis

World Health Organization. WHO announces COVID-19 outbreak a pandemic

Custodian of the Two Holy Mosques approves taking further precautions to limit the spread of novel Coronavirus

Ministry of Interior: Curfew in Jeddah Governorate to be effective from 3:00 p.m. on Sunday, and suspension of entry into and exit from it

Kingdom's government decides to suspend attendance at workplaces in all government agencies for period of (16) days except for health, security, military and electronic security center

The official Saudi Press Agency. An Approval Issued to fully Lift the Curfew from 06 am on Sunday, Ban on Umrah, Visit, Int'l Flights to Continue

International Diabetes Federation

The diabetes control and complications trial/epidemiology of diabetes interventions and complications study at 30 years: overview

Diabetes self-management amid COVID-19 pandemic

Self-management of diabetes mellitus during the Covid-19 pandemic: Recommendations for a resource limited setting

The PHQ-9: validity of a brief depression severity measure

A brief measure for assessing generalized anxiety disorder: the GAD-7

An arabic translation, reliability, and validation of Patient Health Questionnaire in a Saudi sample

T1D Exchange Clinic Network. Depression in adults in the T1D Exchange Clinic Registry

Cohort profiles of the cross-sectional and prospective participant groups in the second Diabetes MILES-Australia (MILES-2) study

Reduction of hypoglycaemia, lifestyle modifications and psychological distress during lockdown following SARS-CoV-2 outbreak in type 1 diabetes

Impact of the COVID-19 lockdown on diabetes patients in Jeddah, Saudi Arabia

The psychological impact of COVID-19 pandemic on the general population of Saudi Arabia

Physical Activity/Exercise and Diabetes: A Position Statement of the American Diabetes Association

Nutritional considerations in type 1 diabetes mellitus

Effects of COVID-19 Lockdown on Glucose Control: Continuous Glucose Monitoring Data From People With Diabetes on Intensive Insulin Therapy

Glycemic Control in Type 1 Diabetes Mellitus During COVID-19 Quarantine and the Role of In-Home Physical Activity

Effects of carbohydrate counting on glucose control and quality of life over 24 weeks in adult patients with type 1 diabetes on continuous subcutaneous insulin infusion: a randomized, prospective clinical trial (GIOCAR)

Important Determinants of Diabetes Control in Insulin Pump Therapy in Patients with Type 1 Diabetes Mellitus

Awareness regarding COVID-19 and problems being faced by young adults with type 1 diabetes mellitus amid nationwide lockdown in India: A qualitative interview study

Association of Blood Glucose Control and Outcomes in Patients with COVID-19 and Pre-existing Type 2 Diabetes

Telemedicine for diabetes care in India during COVID19 pandemic and national lockdown period: Guidelines for physicians

Use and perception of telemedicine in people with type 1 diabetes during the COVID-19 pandemic-Results of a global survey

Impact of lockdown in COVID 19 on glycemic control in patients with type 1 Diabetes Mellitus

Information bias in health research: definition, pitfalls, and adjustment methods